Drug Profile
ONO 5390556
Alternative Names: ONO-5390556Latest Information Update: 01 Sep 2023
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class Antineoplastics
- Mechanism of Action TrkA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 01 Sep 2023 Discontinued - Preclinical for Cancer in Japan (PO)
- 28 May 2020 No recent reports of development identified for preclinical development in Cancer in Japan (PO)
- 22 Apr 2016 Preclinical trials in Cancer in Japan (PO)